2017
DOI: 10.18632/oncotarget.16678
|View full text |Cite
|
Sign up to set email alerts
|

Distinct functions of dynamin isoforms in tumorigenesis and their potential as therapeutic targets in cancer

Abstract: Dynamins and their related proteins participate in the regulation of neurotransmission, antigen presentation, receptor internalization, growth factor signalling, nutrient uptake, and pathogen infection. Recently, emerging findings have shown dynamin proteins can also contribute to the genesis of cancer. This up-to-date review herein focuses on the functionality of dynamin in cancer development. Dynamin 1 and 2 both enhance cancer cell proliferation, tumor invasion and metastasis, whereas dynamin 3 has tumor su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(26 citation statements)
references
References 112 publications
(128 reference statements)
3
20
0
Order By: Relevance
“…DNM2 has been implicated as a therapeutic target for cervical cancer: In Hela cells, dynamin-2 inhibitors have been demonstrated to cause decreased migration and invasion via decreasing the expression of matrix metallopeptidase 9, thereby lowering the rate of cell proliferation (57). Similar to Cav-1, an increase in the expression of DNM2 has been demonstrated to correspond to advances in the tumor stage (19). In the present study, the expression levels of DNM2 and Cav-1 genes exhibited a marked correlation with the progression of bladder tumor stage.…”
Section: Discussionsupporting
confidence: 69%
See 2 more Smart Citations
“…DNM2 has been implicated as a therapeutic target for cervical cancer: In Hela cells, dynamin-2 inhibitors have been demonstrated to cause decreased migration and invasion via decreasing the expression of matrix metallopeptidase 9, thereby lowering the rate of cell proliferation (57). Similar to Cav-1, an increase in the expression of DNM2 has been demonstrated to correspond to advances in the tumor stage (19). In the present study, the expression levels of DNM2 and Cav-1 genes exhibited a marked correlation with the progression of bladder tumor stage.…”
Section: Discussionsupporting
confidence: 69%
“…Similarly, together with Cav-1, DNM2 also mediates effects on cancer formation and progression. The 2 proteins are involved in the endocytosis of a number of receptor proteins, ligands and signaling molecules (19,62). However, it has been suggested that there are several other interlinked signaling pathways that, in response to overexpression of Cav-1 and DNM2, may be activated and/or deactivated, resulting in tumor formation (63).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Functional studies suggest that dynamin proteins can participate in promoting cell migration and metastasis in PDAC cellular and mouse models (43,44). In addition, in a recent study, dynamins and their complexes have been hypothesized as important therapeutic targets in cancer (45). The association between aggressiveness of cancers and expression of dynamins and their protein complexes is well matched with our data, where the alleles associated with decreased survival are associated with an increase in DNMBP gene expression, as shown in GTEx.…”
Section: Discussionsupporting
confidence: 89%
“…The present findings show that a HFA diet induces differential changes in the mammary gland transcriptome, with Dynamin 1 ( Dnm1 ) the top upregulated gene, and Bcl-2-binding component 3 ( Bbc3) the top downregulated gene. Dnm1 plays an essential role in endocytosis and is upregulated in many cancers where it has been suggested to attenuate apoptotic signalling [ 39 ], while Bbc3 which encodes the p53 upregulated modulator of apoptosis (PUMA) is downregulated in some cancers. PUMA is a target of the tumour suppressor protein p53 and is necessary for stress-induced apoptosis [ 40 , 41 ].…”
Section: Discussionmentioning
confidence: 99%